Biopharmaceutical Characterization and Stability of Nabumetone–Cyclodextrins Complexes Prepared by Grinding

<b>Background:</b> Nabumetone (NAB) is a poorly soluble nonsteroidal anti-inflammatory prodrug (BCS class II drug) whose solubility is significantly improved by complexation with cyclodextrins (CDs). <b>Methods</b>: The solid complexes, in a 1:1 molar ratio, were prepared by...

Full description

Saved in:
Bibliographic Details
Main Authors: David Klarić, Željka Soldin, Anna Vincze, Rita Szolláth, György Tibor Balogh, Mario Jug, Nives Galić
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/16/12/1493
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850035844998496256
author David Klarić
Željka Soldin
Anna Vincze
Rita Szolláth
György Tibor Balogh
Mario Jug
Nives Galić
author_facet David Klarić
Željka Soldin
Anna Vincze
Rita Szolláth
György Tibor Balogh
Mario Jug
Nives Galić
author_sort David Klarić
collection DOAJ
description <b>Background:</b> Nabumetone (NAB) is a poorly soluble nonsteroidal anti-inflammatory prodrug (BCS class II drug) whose solubility is significantly improved by complexation with cyclodextrins (CDs). <b>Methods</b>: The solid complexes, in a 1:1 molar ratio, were prepared by mechanochemical activation by grinding, using β-cyclodextrin (β-CD) and its derivatives, hydroxypropyl- and sulfobutylether-β-cyclodextrin (HP-β-CD and SBE-β-CD). The complexation was confirmed by differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), and attenuated total reflectance Fourier-transformed infrared spectroscopy (ATR–FTIR). Obtained products were further characterized regarding their solubility, in vitro dissolution, permeability and chemical stability. <b>Results</b>: Co-grinding with HP-β-CD and SBE-β-CD yielded products that showed in vitro dissolution profiles in hydrochloric acid medium (pH 1.2) that were substantially different from that of pure NAB, yielding dissolution efficiency enhancements of 34.86 ± 1.64 and 58.30 ± 0.28 times, respectively, for the optimized products. Their in vitro dissolution and gastrointestinal permeability were also studied in a low-volume environment at pH 6.8, corresponding to the intestinal environment. Both β-CD derivatives increased NAB dissolution rate and NAB mass transport across the biomimetic membrane. The effect of β-CD derivatives on NAB chemical stability was studied under the stress conditions by the developed and validated UHPLC–DAD–HRMS method. In acidic conditions, pure and complexed NAB was prone to hydrolytic degradation, yielding one degradation product—pharmacologically inactive NAB metabolite. However, under the oxidative conditions at elevated temperatures, 10 NAB degradation products were identified from co-ground samples. All systems were stable during photo- and long-term stability studies. <b>Conclusions</b>: NAB complexes with HP-β-CD and SBE-β-CD are promising candidates for pharmaceutical product development.
format Article
id doaj-art-cab6110be870463e9d366485a49d4efc
institution DOAJ
issn 1999-4923
language English
publishDate 2024-11-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj-art-cab6110be870463e9d366485a49d4efc2025-08-20T02:57:21ZengMDPI AGPharmaceutics1999-49232024-11-011612149310.3390/pharmaceutics16121493Biopharmaceutical Characterization and Stability of Nabumetone–Cyclodextrins Complexes Prepared by GrindingDavid Klarić0Željka Soldin1Anna Vincze2Rita Szolláth3György Tibor Balogh4Mario Jug5Nives Galić6Department of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102a, 10 000 Zagreb, CroatiaDepartment of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102a, 10 000 Zagreb, CroatiaDepartment of Pharmaceutical Chemistry, Semmelweis University, Hőgyes Endre u. 9., H-1092 Budapest, HungaryDepartment of Pharmaceutical Chemistry, Semmelweis University, Hőgyes Endre u. 9., H-1092 Budapest, HungaryDepartment of Pharmaceutical Chemistry, Semmelweis University, Hőgyes Endre u. 9., H-1092 Budapest, HungaryDepartment of Pharmaceutical Technology, Faculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, 10 000 Zagreb, CroatiaDepartment of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102a, 10 000 Zagreb, Croatia<b>Background:</b> Nabumetone (NAB) is a poorly soluble nonsteroidal anti-inflammatory prodrug (BCS class II drug) whose solubility is significantly improved by complexation with cyclodextrins (CDs). <b>Methods</b>: The solid complexes, in a 1:1 molar ratio, were prepared by mechanochemical activation by grinding, using β-cyclodextrin (β-CD) and its derivatives, hydroxypropyl- and sulfobutylether-β-cyclodextrin (HP-β-CD and SBE-β-CD). The complexation was confirmed by differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), and attenuated total reflectance Fourier-transformed infrared spectroscopy (ATR–FTIR). Obtained products were further characterized regarding their solubility, in vitro dissolution, permeability and chemical stability. <b>Results</b>: Co-grinding with HP-β-CD and SBE-β-CD yielded products that showed in vitro dissolution profiles in hydrochloric acid medium (pH 1.2) that were substantially different from that of pure NAB, yielding dissolution efficiency enhancements of 34.86 ± 1.64 and 58.30 ± 0.28 times, respectively, for the optimized products. Their in vitro dissolution and gastrointestinal permeability were also studied in a low-volume environment at pH 6.8, corresponding to the intestinal environment. Both β-CD derivatives increased NAB dissolution rate and NAB mass transport across the biomimetic membrane. The effect of β-CD derivatives on NAB chemical stability was studied under the stress conditions by the developed and validated UHPLC–DAD–HRMS method. In acidic conditions, pure and complexed NAB was prone to hydrolytic degradation, yielding one degradation product—pharmacologically inactive NAB metabolite. However, under the oxidative conditions at elevated temperatures, 10 NAB degradation products were identified from co-ground samples. All systems were stable during photo- and long-term stability studies. <b>Conclusions</b>: NAB complexes with HP-β-CD and SBE-β-CD are promising candidates for pharmaceutical product development.https://www.mdpi.com/1999-4923/16/12/1493nabumetonecyclodextrinsmechanochemistrysolid-state characterizationin vitro permeabilityin vitro dissolution
spellingShingle David Klarić
Željka Soldin
Anna Vincze
Rita Szolláth
György Tibor Balogh
Mario Jug
Nives Galić
Biopharmaceutical Characterization and Stability of Nabumetone–Cyclodextrins Complexes Prepared by Grinding
Pharmaceutics
nabumetone
cyclodextrins
mechanochemistry
solid-state characterization
in vitro permeability
in vitro dissolution
title Biopharmaceutical Characterization and Stability of Nabumetone–Cyclodextrins Complexes Prepared by Grinding
title_full Biopharmaceutical Characterization and Stability of Nabumetone–Cyclodextrins Complexes Prepared by Grinding
title_fullStr Biopharmaceutical Characterization and Stability of Nabumetone–Cyclodextrins Complexes Prepared by Grinding
title_full_unstemmed Biopharmaceutical Characterization and Stability of Nabumetone–Cyclodextrins Complexes Prepared by Grinding
title_short Biopharmaceutical Characterization and Stability of Nabumetone–Cyclodextrins Complexes Prepared by Grinding
title_sort biopharmaceutical characterization and stability of nabumetone cyclodextrins complexes prepared by grinding
topic nabumetone
cyclodextrins
mechanochemistry
solid-state characterization
in vitro permeability
in vitro dissolution
url https://www.mdpi.com/1999-4923/16/12/1493
work_keys_str_mv AT davidklaric biopharmaceuticalcharacterizationandstabilityofnabumetonecyclodextrinscomplexespreparedbygrinding
AT zeljkasoldin biopharmaceuticalcharacterizationandstabilityofnabumetonecyclodextrinscomplexespreparedbygrinding
AT annavincze biopharmaceuticalcharacterizationandstabilityofnabumetonecyclodextrinscomplexespreparedbygrinding
AT ritaszollath biopharmaceuticalcharacterizationandstabilityofnabumetonecyclodextrinscomplexespreparedbygrinding
AT gyorgytiborbalogh biopharmaceuticalcharacterizationandstabilityofnabumetonecyclodextrinscomplexespreparedbygrinding
AT mariojug biopharmaceuticalcharacterizationandstabilityofnabumetonecyclodextrinscomplexespreparedbygrinding
AT nivesgalic biopharmaceuticalcharacterizationandstabilityofnabumetonecyclodextrinscomplexespreparedbygrinding